Clinical Trial Update: Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating tolerability of combining lapatinib with trastuzumab in adults aged 60 and older with HER2-positive locally advanced or metastatic brea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)
• Tykerb (lapatinib)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Breast Neoplasms, HER2/Neu Positive | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2022-07-28